Generate Biomedicines, Inc.
GENBNasdaqCIK 2100782HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|
| Revenue | $m | 8.8Revenue, period not labelled, three months to 2025-03-31$8.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 10.1Revenue, period not labelled, three months to 2025-06-30$10.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 7.2Revenue, Q1 FY2026, three months to 2026-03-31$7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 6.3Revenue, Q2 FY2026, three months to 2026-06-30$6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Research and development | $m | 46.8Research and development, period not labelled, three months to 2025-03-31$46.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 59.7Research and development, period not labelled, three months to 2025-06-30$59.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 57.8Research and development, Q1 FY2026, three months to 2026-03-31$57.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 64.3Research and development, Q2 FY2026, three months to 2026-06-30$64.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Operating income | $m | (48.2)Operating income, period not labelled, three months to 2025-03-31−$48.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | (60.2)Operating income, period not labelled, three months to 2025-06-30−$60.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (64.1)Operating income, Q1 FY2026, three months to 2026-03-31−$64.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | (71.6)Operating income, Q2 FY2026, three months to 2026-06-30−$71.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Interest expense | $m | 0.4Interest expense, period not labelled, three months to 2025-03-31$368.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 0.3Interest expense, period not labelled, three months to 2025-06-30$307.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 0.2Interest expense, Q1 FY2026, three months to 2026-03-31$182.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 0.2Interest expense, Q2 FY2026, three months to 2026-06-30$155.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Income tax | $m | 0.1Income tax, period not labelled, three months to 2025-03-31$56.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 0.0Income tax, period not labelled, three months to 2025-06-30$44.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 0.0Income tax, Q1 FY2026, three months to 2026-03-31$28.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 0.1Income tax, Q2 FY2026, three months to 2026-06-30$53.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Net income | $m | (41.7)Net income, period not labelled, three months to 2025-03-31−$41.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (52.4)Net income, period not labelled, three months to 2025-06-30−$52.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (61.4)Net income, Q1 FY2026, three months to 2026-03-31−$61.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (67.3)Net income, Q2 FY2026, three months to 2026-06-30−$67.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Diluted EPS | $ per share | (1.62)Diluted EPS, period not labelled, three months to 2025-03-31−$1.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | (1.94)Diluted EPS, period not labelled, three months to 2025-06-30−$1.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (1.07)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | (0.52)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Basic EPS | $ per share | (1.62)Basic EPS, period not labelled, three months to 2025-03-31−$1.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | (1.94)Basic EPS, period not labelled, three months to 2025-06-30−$1.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (1.07)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | (0.52)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
Balance sheet
| Line item | Unit | period not labelled2024-12-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | period not labelled2025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | not reported | 221Cash and equivalents, period not labelled, at 2025-03-31$220.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 154Cash and equivalents, period not labelled, at 2025-06-30$154.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 122Cash and equivalents, period not labelled, at 2025-12-31$121.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 161Cash and equivalents, Q1 FY2026, at 2026-03-31$160.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 135Cash and equivalents, Q2 FY2026, at 2026-06-30$135.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Current assets | $m | not reported | not reported | not reported | 234Current assets, period not labelled, at 2025-12-31$234.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 535Current assets, Q1 FY2026, at 2026-03-31$535.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 470Current assets, Q2 FY2026, at 2026-06-30$470.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Total assets | $m | not reported | not reported | not reported | 330Total assets, period not labelled, at 2025-12-31$330.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 626Total assets, Q1 FY2026, at 2026-03-31$625.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 562Total assets, Q2 FY2026, at 2026-06-30$561.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Current liabilities | $m | not reported | not reported | not reported | 82.2Current liabilities, period not labelled, at 2025-12-31$82.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 58.4Current liabilities, Q1 FY2026, at 2026-03-31$58.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 56.6Current liabilities, Q2 FY2026, at 2026-06-30$56.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Total liabilities | $m | not reported | not reported | not reported | 142Total liabilities, period not labelled, at 2025-12-31$141.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 111Total liabilities, Q1 FY2026, at 2026-03-31$110.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 106Total liabilities, Q2 FY2026, at 2026-06-30$105.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
| Shareholders' equity | $m | (435)Shareholders' equity, period not labelled, at 2024-12-31−$434.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (471)Shareholders' equity, period not labelled, at 2025-03-31−$471.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (518)Shareholders' equity, period not labelled, at 2025-06-30−$517.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | (616)Shareholders' equity, period not labelled, at 2025-12-31−$616.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 515Shareholders' equity, Q1 FY2026, at 2026-03-31$514.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure | 456Shareholders' equity, Q2 FY2026, at 2026-06-30$456.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336437.Report this figure |
Cash flow
| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|
| Operating cash flow | $m | (53.2)Operating cash flow, period not labelled, three months to 2025-03-31−$53.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | (48.8)Operating cash flow, period not labelled, three months to 2025-06-30−$48.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336437. Derived: 6-month figure less the 3-month figure.Report this figure | (80.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$80.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | (57.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$57.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336437. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | 0.8Capital expenditure, period not labelled, three months to 2025-03-31$751.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 0.2Capital expenditure, period not labelled, three months to 2025-06-30$154.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336437. Derived: 6-month figure less the 3-month figure.Report this figure | 3.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210059.Report this figure | 0.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$933.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336437. Derived: 6-month figure less the 3-month figure.Report this figure |
Shares
| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 32.8 | 33.0 | 64.9 | 128 |
Shares outstanding: 128.35m at Jul 29, 2026, from the cover of the 10-Q filed Aug 6, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.